---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-168830"
form_type: "8-K"
ticker: "RNTX"
cik: "0001420565"
company_name: "Rein Therapeutics, Inc."
filed_at: "2025-07-30T23:59:59+00:00"
generated_at: "2026-05-17T22:57:06.888761+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Rein Therapeutics enters up to $21M financing with Yorkville via PPA and SEPA

## Summary
- Pre-Paid Advance Agreement: up to $6M; initial $1M advance at 95% net ($0.95M); 8% annual interest rising to 18% on default.
- Standby Equity Purchase Agreement: up to $15M over 36 months; shares sold at 96% of lowest 3-day VWAP.
- Floor price set at $0.28 per share; Yorkville may require share issuance at lower of 115% of VWAP or 95% of lowest 7-day VWAP.
- Commitment fee of $300k paid as 213,099 shares plus $25k structuring fees; Exchange Cap limited to 19.9% of outstanding shares.
- Proceeds used for general corporate purposes; shares registered on Form S-3 (File No. 333-287342).

## SEC filing metadata
- accession: 0001193125-25-168830
- form_type: 8-K
- ticker: RNTX
- cik: 0001420565
- company_name: Rein Therapeutics, Inc.
- filed_at: 2025-07-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420565/000119312525168830/0001193125-25-168830-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420565/000119312525168830/d56953d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-168830
- JSON: https://secwatch.observer/filing/0001193125-25-168830.json
- Plain text: https://secwatch.observer/filing/0001193125-25-168830.txt

## Key facts
- Debt Financings
  Rein Therapeutics, Inc. incurred credit facility of up to $6.0 million with YA II PN, Ltd. at 8%.
  - Instrument: credit facility
  - Principal: up to $6.0 million
  - Counterparty: YA II PN, Ltd.
  - Rate: 8%
  - Event: incurrence
  source text: (the “Company”) entered into a Pre-Paid Advance Agreement (the “PPA”) with YA II PN, Ltd., a Cayman Islands exempt limited partnership (“Yorkville”). In accordance with the terms of the PPA, the Company may request pre-paid advances of up to $6.0 million from Yorkville (each, a “Pre-Paid Advance”) over a 12-month period, subject to certain limitations and conditions set forth in the PPA.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420565/000119312525168830/0001193125-25-168830-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.